Stimulates hepatic IGF-1 production, anabolic signalling in muscle via IGF-1R, adipose lipolysis, and GH-induced insulin resistance at supraphysiological doses
For example, curcumin has been evaluated in Phase II clinical studies in pancreatic cancer and colorectal cancer patients, where oral doses up to 8 g/day demonstrated acceptable safety but limited systemic exposure, highlighting pharmacokinetic challenges
Were exposed to free radicals from environmental pollution, stress, overconsumption of alcohol, and other factors
It is important to follow proper guidelines and consider professional advice, especially for long-term or repeated use
TB-500's strengths lie in general tissue regeneration and recovery
Animal studies used doses up to 1.1 mg per kilogram of body weight with no adverse effects observed